Risk Of Treatment Failure And Death Following Deviation From Radiation Protocols
11/01/2012
Implementing measures to ensure radiation therapy protocols are followed not only decreases deviations, but it can also improve overall survival in cancer patients, Thomas Jefferson University Hospital researchers suggest in a first-of-its kind study presented during a plenary session at the American Society for Radiation Oncology (ASTRO) 54th Annual Meeting in Boston...
By studying a specific part of the male DNA, it may be possible to refine the interpretation of PSA tests. This would reduce the risk of men being treated for prostate cancer unnecessarily...
Prognosis Hope For Prostate Cancer
11/01/2012
Scientists have discovered a molecular 'tell' in laboratory experiments that could help doctors determine the severity of a patient's prostate cancer. Cancer of the prostate - the most common male cancer in the UK - presents in two distinct ways: a low-risk type, which may never cause any symptoms, and a high-risk form that needs treatment to prevent it spreading to other parts of the body...
Waiting too long after a hysterectomy to begin radiation therapy may increase the risk of uterine cancer recurrence, according to a new study from researchers at Henry Ford Hospital in Detroit...
Molecule Discovered With A Promising Function In Terms Of Cancer Treatment
11/01/2012
One of the current challenges in terms of cancer treatment is how it can be best adapted to patients: today the emphasis is on personalised treatment (factoring in genetic and metabolic profiles). In response to this growing need for personalisation, there is an increasing demand for fundamental research to develop adapted future treatments...
Elderly women with early-stage breast cancer live longer with radiation therapy and surgery compared with surgery alone, researchers at the University of Maryland School of Medicine have found...
Adcetris (Brentuximab Vedotin) Gets Conditional European Marketing Authorization
10/31/2012
Adcetris (Brentuximab Vedotin) has been approved in the European Union for patients with certain types of lymphoma, Millennium announced today...
Adcetris (Brentuximab Vedotin) Gets Conditional European Marketing Authorization
10/31/2012
Adcetris (Brentuximab Vedotin) has been approved in the European Union for patients with certain types of lymphoma, Millennium announced today...
Chinese Food Bean May Protect Against Sepsis
10/31/2012
A bean commonly found in Chinese food protects people against the potentially fatal condition sepsis. The finding, published in the current issue of Evidence-based Complementary and Alternative Medicine (eCAM), came from a team of experts at The Feinstein Institute for Medical Research. HMGB1, a deoxyribonucleic acid (DNA) protein, is responsible for regulating inflammation...
Chinese Food Bean May Protect Against Sepsis
10/31/2012
A bean commonly found in Chinese food protects people against the potentially fatal condition sepsis. The finding, published in the current issue of Evidence-based Complementary and Alternative Medicine (eCAM), came from a team of experts at The Feinstein Institute for Medical Research. HMGB1, a deoxyribonucleic acid (DNA) protein, is responsible for regulating inflammation...